Publications by authors named "Aleksandra Aitullina"

Aims: Acute neutropenia induced by antibiotics is a rare side effect of this frequently prescribed class of drugs. We aim to find similarities and differences between reported cases.

Methods: Through a database search (PubMed, 1968-2020), we identified published case reports and extracted, among other data, patient demographics, duration of treatment with the respective agent, and duration of recovery.

View Article and Find Full Text PDF

Background Colistin is a potentially nephrotoxic antibiotic used for the management of multidrug-resistant bacterial infections in critically ill patients. Co-administration with other nephrotoxins was reported as a potentially modifiable risk factor of colistin acute kidney injury. Objective To establish the role of colistin dosing and co-medications in development of colistin kidney injury.

View Article and Find Full Text PDF

Colistin is used for the treatment of multidrug-resistant (MDR) Gram-negative bacteria infection in critically ill patients. It is recommended to adjust the dose in cases of renal impairment but not in cases of augmented renal clearance (ARC). The aim of this study was to determine colistin use pattern in patients with different renal functional states.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate mutations linked to Leber hereditary optic neuropathy (LHON) among patients in Latvia and assess factors like heteroplasmy and mitochondrial haplogroups that might influence LHON outcomes.
  • Twelve patients suspected of having LHON underwent genetic analysis, including sequencing for known mutations and tests for heteroplasmy; the study identified specific mutations in some participants.
  • The findings confirmed LHON in four patients and highlighted the need for further research to explore the significance of certain polymorphisms and their relationship with mitochondrial genetics.
View Article and Find Full Text PDF

Introduction: Clopidogrel ineffectiveness is a serious problem in antiplatelet therapy. Many factors may contribute to this phenomenon. One of them is clopidogrel drug-drug interaction with CYP2C19 and CYP3A4 enzyme inhibitors.

View Article and Find Full Text PDF